Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54,820 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.
Wei L, Wedemeyer H, Liaw YF, Chan HL, Piratvisuth T, Marcellin P, Jia J, Tan D, Chow WC, Brunetto MR, Diago M, Gurel S, Morozov V, He H, Zhu Y, Wat C, Surujbally B, Thompson AJ. Wei L, et al. Among authors: zhu y. PLoS One. 2018 Jul 17;13(7):e0199198. doi: 10.1371/journal.pone.0199198. eCollection 2018. PLoS One. 2018. PMID: 30016335 Free PMC article. Clinical Trial.
Using exploratory pharmacokinetic and pharmacodynamic analyses to predict the probability of flu-like symptoms in healthy volunteers and patients with chronic hepatitis B treated with the toll-like receptor 7 agonist ruzotolimod.
Jiang Q, Zhang Y, Duan D, Retout S, Upmanyu R, Glavini K, Triyatni M, Zhu Y, Grippo JF, Jin Y. Jiang Q, et al. Among authors: zhu y. Clin Transl Sci. 2024 Aug;17(8):e13896. doi: 10.1111/cts.13896. Clin Transl Sci. 2024. PMID: 39119977 Free PMC article. Clinical Trial.
TLR7 agonist RO7020531 versus placebo in healthy volunteers and patients with chronic hepatitis B virus infection: a randomised, observer-blind, placebo-controlled, phase 1 trial.
Yuen MF, Balabanska R, Cottreel E, Chen E, Duan D, Jiang Q, Patil A, Triyatni M, Upmanyu R, Zhu Y, Canducci F, Gane EJ. Yuen MF, et al. Among authors: zhu y. Lancet Infect Dis. 2023 Apr;23(4):496-507. doi: 10.1016/S1473-3099(22)00727-7. Epub 2022 Dec 9. Lancet Infect Dis. 2023. PMID: 36509100 Clinical Trial.
High-performance 2D electronic devices enabled by strong and tough two-dimensional polymer with ultra-low dielectric constant.
Fang Q, Yi K, Zhai T, Luo S, Lin CY, Ai Q, Zhu Y, Zhang B, Alvarez GA, Shao Y, Zhou H, Gao G, Liu Y, Xu R, Zhang X, Wang Y, Tian X, Zhang H, Han Y, Zhu H, Zhao Y, Tian Z, Zhong Y, Liu Z, Lou J. Fang Q, et al. Among authors: zhu y. Nat Commun. 2024 Dec 30;15(1):10780. doi: 10.1038/s41467-024-53935-6. Nat Commun. 2024. PMID: 39737907
54,820 results
You have reached the last available page of results. Please see the User Guide for more information.